Fig. 1From: Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approachA MECP2 expression levels for RTT, MDS and control individuals obtained by RNAseq. B MeCP2 intensity levels for RTT, MDS and control individuals obtained by proteomics. C Pearson’s correlation between the severity score of RTT patients and MeCP2 levelsBack to article page